|
Xolair gets asthma green light from NICE
PMLiVE The UK's National Institute for Health and Care Excellence (NICE) has recommended the use of Novartis' asthma injection Xolair as an add-on therapy on the NHS in England and Wales. The final guidance means Xolair (omalizumab) is now an option for … |
View full post on asthma – Google News